Glucagon like peptide 1 receptor: mechanisms and advances in therapy Signal Transduction and Targeted Therapy Identification and utility exploration of a highly potent and long acting bullfrog GLP 1 analogue in GLP 1 and amylin combination therapy ScienceDirect Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Triple Agonism Based Therapies for Obesity Current Cardiovascular Risk Reports Springer Nature Link